HFS
EWTX icon

Hughes Financial Services’s Edgewise Therapeutics EWTX Stock Holding History

Hughes Financial Services’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$122 Buy
3
+1
+50% +$34 ﹤0.01% 1400
2026
Q1 		$63 Buy
+2
New +$58 ﹤0.01% 1404

Other funds holding EWTX

PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM
CCMG
Connecticut Capital Management Group Milford, Connecticut $124M AUM
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Hughes Financial Services's EWTX Position: Q2 2026 in Review

Hughes Financial Services increased its Edgewise Therapeutics (EWTX) stake by 50% in Q2 2026, buying an estimated $34 and bringing the position to 3 shares worth $122. The position accounts for ﹤0.01% of the portfolio, ranked #1400.

Hughes Financial Services first reported a position in EWTX in Q1 2026 and has held it in 2 quarters since. 24 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • Hughes Financial Services held 3 shares of Edgewise Therapeutics worth $122 as of Q2 2026.
  • Hughes Financial Services bought 1 Edgewise Therapeutics share in Q2 2026, an estimated $34.
  • Edgewise Therapeutics made up ﹤0.01% of Hughes Financial Services's portfolio in Q2 2026, its #1400 holding.
  • Hughes Financial Services first reported a position in Edgewise Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 24 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on Hughes Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.